Table 4: Summary of the nature and frequency of noninfectious risks associated with red blood cell and plasma transfusion | ||
Complication | Usual cause | Frequency |
Acute hemolytic reaction121,122,123 | ABO incompatability | 1 per 25 000 RBC units |
Delayed hemolytic reaction122,123126 | Hemolysis due to minor blood group incompatability | 1 per 25009000 RBC units |
RBC alloimmunization127 | Recipient antibody response to donor antigen | About 8% of patients transfused with RBCs |
Nonimmune hemolytic reaction122,128 | Physical or chemical degradation of RBCs (freezing, heating or addition of a hemolytic drug or solution) | Unknown |
Febrile, nonhemolytic reaction or chills without fever122,123,129 | Recipient antibody to donor WBC or platelet antigen or accumulation of cytokines in blood units during storage or both | 1 per 100 RBC units |
Anaphylaxis122,123,128 | Complement activation | 1 per 20 00050 000 units (RBC or plasma) |
Urticarial reactions122,123 | Antibody-mediated response to donor plasma proteins | 1 per 100300 plasma transfusions (probably similar with RBC transfusions) |
Transfusion-related acute lung injury122,123 | Complement-mediated pulmonary edema | Unknown |
Graft-versus-host disease79,130,123,131,132 | Engraftment of immunocompetent donor lymphocytes in host | Unknown |
Postransfusion purpura122,133,134 | Recipient develops antibodies against donor and recipient platelets | Unknown |
Passive alloimmune thrombocytopenia135,136 | Donor blood contains platelet-specific alloantibody that results in abrupt thrombocytopenia in the recipient | Rare |
Circulatory overload122,131 | Excess intravascular volume | 1% of transfused patients |
Hypothermia, coagulopathy, acidbase disturbances, hypocalcemia, electrolyte abnormalities and citrate toxicity associated with massive transfusion88,90,94,137140 | Loss, consumption or dilution of blood elements | Related to volume transfused, unlikely to be seen when < 1.5 blood volumes replaced |
Iron overload | Chronic RBC transfusion therapy (each unit contains 200 mg of iron) | Variable, according to number of RBC units transfused; begins after the tranfusion of > 20 RBC units |